14-day Premium Trial Subscription Try For FreeTry Free

Latest Data & Signals Issued

Signal Type Signal Value Data
Score -2.091 9 days ( 5.80 % )
Last Price £3.25 0 %
High/ Low £3.25 - £3.25 -2.31%
Chg 7 Days -2.99 % $3.35 £3.25
Chg 30 Days -7.80 % $3.53 £3.25
Chg 12 mos -67.01 % $9.85 £3.25
Trend - 3 mos -30.46 % Width: 31.79 %
Trend - 12 mos -31.78 % Width: 1,025.88 %
Pred. range - 3 mos £1.86 - £2.45 -42.71 % - -24.49 %
Pred. range - 12 mos £0.696 - £7.83 -78.59 % - 141.03 %
Short MA avg 3 mos Sell Apr 17, 2024 - 13 days
Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short/Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short MA avg 12 mos Buy Dec 04, 2023 - 105 days
Long MA avg 12 mos Sell Dec 08, 2023 - 101 days
Short/Long MA avg 12 mos Sell Dec 21, 2023 - 92 days
Pivot Short Buy May 02, 2024 - 2 days
Bollinger Sell Nov 30, -1 - N/A days
MACD Sell No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!

About The Valspar Corp

The Valspar ValiRx plc, a biopharmaceutical company, engages in the development of oncology therapeutics and companion diagnostics in the United Kingdom. The company's lead drug candidates include VAL201, a small molecule that has completed Phase I/II trials for the treatment of prostate cancer and other hormone associated solid tumours comprising breast and ovarian cancer; and VAL401, a reformulation of anti-psychotic drug risperidone, which has completed P... VAL.L Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT